Nasopharyngeal Cancer

Our head and neck specialists offer evidence-based, compassionate care for people with nasopharyngeal cancer, which affects the nasopharynx, located at the top part of the throat. Through our clinical trials, we offer access to new imaging techniques that help your doctors diagnose nasopharyngeal cancer and guide treatment decisions. Then, our team of radiation oncologists, medical oncologists, and other experts develops a personalized care plan that’s right for you.

Clinical Trials and Research Studies

Phase 2

A PHASE 2 STUDY OF ALKS 4230 IN COMBINATION WITH ANTI-PD-1 (PEMBROLIZUMAB) IN PATIENTS WITH ADVANCED OR RECURRENT HEAD AND NECK SQUAMOUS CELL CANCER CURRENTLY ON TREATENT WITH ANTI-PD-(L)1 WITHOUT HAVING ACHIEVED A COMPLETE REMISSION

Learn More

Phase 6

NRG-HN004 Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin.

Learn More

Phase -1

The AIM-HN and SEQ-HN Study: A 2 Cohort Non-comparative Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)

Learn More

Phase 3

MK-3475 (SCH 9000475) as neoadjuvant and adjuvant therapy in Stage III-IVA resectable

Learn More